Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002347229 | SCV002652124 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-12-21 | criteria provided, single submitter | clinical testing | The p.P180Q variant (also known as c.539C>A), located in coding exon 4 of the AIP gene, results from a C to A substitution at nucleotide position 539. The proline at codon 180 is replaced by glutamine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004572307 | SCV005060243 | uncertain significance | Somatotroph adenoma | 2023-11-14 | criteria provided, single submitter | clinical testing |